Skip to main content
Top
Published in: The Journal of Headache and Pain 1/2019

Open Access 01-12-2019 | Migraine | Research article

Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center

Published in: The Journal of Headache and Pain | Issue 1/2019

Login to get access

Abstract

Background

Migraine is a common and severely disabling neurological disorder affecting millions of patients in Europe. Despite the availability of evidence-based national and international guidelines, the management of migraine patients often remains poor, which is often attributed to a low availability of headache specialists. The aim of this study was to investigate the adherence to national guidelines and to assess the possible potential of optimized therapy regimens in migraine patients.

Methods

We collected data of migraine patients presenting to our out-patient clinic via standardized questionnaires regarding headache, diagnostics and experience with previous treatments. We also assessed the efficacy of treatment started by our center.

Results

1,935 migraine patients were included between 2010 and 2018. In the 12 months before consulting our headache clinic 89.5% of the patients had consulted a general practitioner and 74.9% had consulted a neurologist because of their migraine. Nevertheless, 50% of the patients underwent unnecessary diagnostics and 34.2% had not been treated according to evidence-based treatment guidelines. Out of 1,031 patients who had not been prescribed a preventative treatment 627 (60.8%) had in average 3 or more migraine attacks per month and thus qualified for a preventative treatment. These patients missed in the 3 months prior to consultation on average 5 work or school days. Initiating a preventative treatment was effective in 71.2% of the patients, that provided follow-up data.

Conclusions

Our data suggest, that many migraine patients to this day do not receive state-of-the-art therapy. Adherence to national and international European guidelines could improve the outcome in migraine patients. Future research should try to answer why guidelines are not followed.
Literature
1.
go back to reference Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622CrossRef Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622CrossRef
2.
go back to reference Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF et al (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol 16(11):877–897CrossRef Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF et al (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol 16(11):877–897CrossRef
3.
go back to reference Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 27(3):193–210CrossRef Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 27(3):193–210CrossRef
4.
go back to reference Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703–711CrossRef Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703–711CrossRef
5.
go back to reference Diener H-C, Holle-Lee D, Nägel S, Dresler T, Gaul C, Göbel H et al (2019) Treatment of migraine attacks and prevention of migraine: guidelines by the German migraine and headache society and the German Society of Neurology. Clin Transl Neurosci 3(1, 1) 2514183X18823377CrossRef Diener H-C, Holle-Lee D, Nägel S, Dresler T, Gaul C, Göbel H et al (2019) Treatment of migraine attacks and prevention of migraine: guidelines by the German migraine and headache society and the German Society of Neurology. Clin Transl Neurosci 3(1, 1) 2514183X18823377CrossRef
6.
go back to reference Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A et al (2009) EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol 16(9):968–981CrossRef Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A et al (2009) EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol 16(9):968–981CrossRef
7.
go back to reference Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ (2018) Poor medical care for people with migraine in Europe – evidence from the Eurolight study. J Headache Pain 19(1):10CrossRef Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ (2018) Poor medical care for people with migraine in Europe – evidence from the Eurolight study. J Headache Pain 19(1):10CrossRef
8.
go back to reference Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S et al (2011) Time delay from onset to diagnosis of migraine. Headache J Head Face Pain 51(2):232–236CrossRef Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S et al (2011) Time delay from onset to diagnosis of migraine. Headache J Head Face Pain 51(2):232–236CrossRef
9.
go back to reference Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9(3):285–298CrossRef Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9(3):285–298CrossRef
10.
go back to reference Radtke A, Neuhauser H (2012) Low rate of self-awareness and medical recognition of migraine in Germany. Cephalalgia. 32(14):1023–1030CrossRef Radtke A, Neuhauser H (2012) Low rate of self-awareness and medical recognition of migraine in Germany. Cephalalgia. 32(14):1023–1030CrossRef
11.
go back to reference Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 56(suppl 1):S20CrossRef Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 56(suppl 1):S20CrossRef
12.
go back to reference Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia Int J Headache. 2018;38(1):1–1211 Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia Int J Headache. 2018;38(1):1–1211
13.
go back to reference Holroyd KA, Penzien DB (1990) Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain. 42(1):1–13CrossRef Holroyd KA, Penzien DB (1990) Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain. 42(1):1–13CrossRef
15.
go back to reference Krobot KJ, Steinberg HW, Pfaffenrath V (1999) Migraine prescription density and recommendations. Results of the PCAOM study. Cephalalgia Int J Headache 19(5):511–519CrossRef Krobot KJ, Steinberg HW, Pfaffenrath V (1999) Migraine prescription density and recommendations. Results of the PCAOM study. Cephalalgia Int J Headache 19(5):511–519CrossRef
16.
go back to reference Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB (2015) Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 35(6):478–488CrossRef Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB (2015) Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 35(6):478–488CrossRef
17.
go back to reference Gallagher RM, Alam R, Shah S, Mueller L, Rogers JJ (2005) Headache in medical education: medical schools, neurology and family practice residencies. Headache J Head Face Pain. 45(7):866–873CrossRef Gallagher RM, Alam R, Shah S, Mueller L, Rogers JJ (2005) Headache in medical education: medical schools, neurology and family practice residencies. Headache J Head Face Pain. 45(7):866–873CrossRef
18.
go back to reference Young WB, Rosen N, Sheftell F (2007) Square one: headache education for the medical student. Headache J Head Face Pain. 47(3):351–354CrossRef Young WB, Rosen N, Sheftell F (2007) Square one: headache education for the medical student. Headache J Head Face Pain. 47(3):351–354CrossRef
19.
go back to reference Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 84(7):688–695CrossRef Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 84(7):688–695CrossRef
20.
go back to reference May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455–464CrossRef May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455–464CrossRef
Metadata
Title
Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center
Publication date
01-12-2019
Published in
The Journal of Headache and Pain / Issue 1/2019
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/s10194-019-1034-8

Other articles of this Issue 1/2019

The Journal of Headache and Pain 1/2019 Go to the issue